The sodium-glucose cotransporter-2 inhibitor canagliflozin alleviates endothelial dysfunction in a rat bypass model
Ischemia/reperfusion (IR) injury during coronary artery bypass grafting surgery has detrimental impacts on endothelial integrity and function. Studies have suggested that canagliflozin (CANA) mitigates the risk of cardiovascular events, independently of diabetes. We hypothesized that the supplementa...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
February 2026
|
| In: |
Biochemical pharmacology
Year: 2026, Jahrgang: 244, Pages: 1-12 |
| ISSN: | 1873-2968 |
| DOI: | 10.1016/j.bcp.2025.117601 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.bcp.2025.117601 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0006295225008664 
|
| Verfasserangaben: | Ming Ma, Shuo Lian, Patricia Kraft, Tobias Mayer, Alex Ali Sayour, Matthias Karck, Gábor Szabó, Sevil Korkmaz-Icöz |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1960478435 | ||
| 003 | DE-627 | ||
| 005 | 20260210084234.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 260210s2026 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bcp.2025.117601 |2 doi | |
| 035 | |a (DE-627)1960478435 | ||
| 035 | |a (DE-599)KXP1960478435 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ma, Ming |e VerfasserIn |0 (DE-588)1389395367 |0 (DE-627)1960478664 |4 aut | |
| 245 | 1 | 4 | |a The sodium-glucose cotransporter-2 inhibitor canagliflozin alleviates endothelial dysfunction in a rat bypass model |c Ming Ma, Shuo Lian, Patricia Kraft, Tobias Mayer, Alex Ali Sayour, Matthias Karck, Gábor Szabó, Sevil Korkmaz-Icöz |
| 246 | 3 | 0 | |a two |
| 264 | 1 | |c February 2026 | |
| 300 | |b Illustrationen | ||
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online verfügbar: 4. Dezember 2025, Artikelversion: 8. Dezember 2025 | ||
| 500 | |a Gesehen am 10.02.2026 | ||
| 520 | |a Ischemia/reperfusion (IR) injury during coronary artery bypass grafting surgery has detrimental impacts on endothelial integrity and function. Studies have suggested that canagliflozin (CANA) mitigates the risk of cardiovascular events, independently of diabetes. We hypothesized that the supplementation and/or administration of CANA protects vascular grafts in a bypass model in non-diabetic Lewis rats. The aortic arches of control rats (n = 9) were harvested, aortic rings were prepared, then mounted in organ baths. In the IR and IR + CANAsuppl groups (n = 8/group), aortic arches were preserved in either saline or CANA-supplemented saline (5 µM) for 1 h at 4 °C before transplantation. In the IR + CANAinject and IR + CANAsuppl+inject groups (n = 9/group), aortic arches were preserved in cold saline or CANA for 1 h and recipients received CANA (10 µg/kg, intravenous) 5 min prior to reperfusion. After 1 h of in vivo blood reperfusion, ex vivo vascular function was assessed and immunohistochemistry was performed. The decreased maximum relaxation (Rmax) to acetylcholine in the IR group compared to controls (20 ± 3 % vs 83 ± 2 %, p < 0.05) was improved in both the IR + CANAinject (36 ± 2 % vs. 20 ± 3 %, p < 0.05) and IR + CANAsuppl+inject (45 ± 3 % vs. 20 ± 3 %, p < 0.05) groups. Additionally, the IR + CANAsuppl+inject rings exhibited a further increased Rmax to acetylcholine compared to both the IR + CANAsuppl (45 ± 3 % vs. 31 ± 2 %, p < 0.05) and IR + CANAinject (45 ± 3 % vs. 36 ± 2 %, p < 0.05) groups. Increased DNA strand breaks in the IR group compared to controls were decreased in all CANA groups. The reduced immunoreactivity of CD-31 was ameliorated in the IR + CANAinject and IR + CANAsuppl+inject groups. CANA alleviates endothelial dysfunction induced by IR injury in a rodent model of revascularization. | ||
| 650 | 4 | |a Canagliflozin | |
| 650 | 4 | |a Coronary artery bypass | |
| 650 | 4 | |a Endothelial function | |
| 650 | 4 | |a Ischemia/reperfusion injury | |
| 700 | 1 | |a Lian, Shuo |d 1991- |e VerfasserIn |0 (DE-588)1326611658 |0 (DE-627)188623891X |4 aut | |
| 700 | 1 | |a Kraft, Patricia |e VerfasserIn |0 (DE-588)1241910367 |0 (DE-627)1771802006 |4 aut | |
| 700 | 1 | |a Mayer, Tobias |e VerfasserIn |0 (DE-588)1329118723 |0 (DE-627)1888291419 |4 aut | |
| 700 | 1 | |a Sayour, Alex Ali |e VerfasserIn |4 aut | |
| 700 | 1 | |a Karck, Matthias |d 1961- |e VerfasserIn |0 (DE-588)130833525 |0 (DE-627)505909340 |0 (DE-576)298366169 |4 aut | |
| 700 | 1 | |a Szabó, Gábor |d 1969- |e VerfasserIn |0 (DE-588)1022955152 |0 (DE-627)717338681 |0 (DE-576)366215485 |4 aut | |
| 700 | 1 | |a Korkmaz-İçöz, Sevil |e VerfasserIn |0 (DE-588)1062748697 |0 (DE-627)806830336 |0 (DE-576)420147845 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biochemical pharmacology |d Amsterdam [u.a.] : Elsevier Science, 1958 |g 244(2026) vom: Feb., Artikel-ID 117601, Seite 1-12 |h Online-Ressource |w (DE-627)30631777X |w (DE-600)1496199-4 |w (DE-576)081952929 |x 1873-2968 |7 nnas |a The sodium-glucose cotransporter-2 inhibitor canagliflozin alleviates endothelial dysfunction in a rat bypass model |
| 773 | 1 | 8 | |g volume:244 |g year:2026 |g month:02 |g elocationid:117601 |g pages:1-12 |g extent:12 |a The sodium-glucose cotransporter-2 inhibitor canagliflozin alleviates endothelial dysfunction in a rat bypass model |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.bcp.2025.117601 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |7 0 |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0006295225008664 |x Verlag |z kostenfrei |3 Volltext |7 0 |
| 951 | |a AR | ||
| 992 | |a 20260210 | ||
| 993 | |a Article | ||
| 994 | |a 2026 | ||
| 998 | |g 1062748697 |a Korkmaz-İçöz, Sevil |m 1062748697:Korkmaz-İçöz, Sevil |d 910000 |d 910200 |e 910000PK1062748697 |e 910200PK1062748697 |k 0/910000/ |k 1/910000/910200/ |p 8 |y j | ||
| 998 | |g 1022955152 |a Szabó, Gábor |m 1022955152:Szabó, Gábor |d 910000 |d 910200 |e 910000PS1022955152 |e 910200PS1022955152 |k 0/910000/ |k 1/910000/910200/ |p 7 | ||
| 998 | |g 130833525 |a Karck, Matthias |m 130833525:Karck, Matthias |d 910000 |d 910200 |e 910000PK130833525 |e 910200PK130833525 |k 0/910000/ |k 1/910000/910200/ |p 6 | ||
| 998 | |g 1329118723 |a Mayer, Tobias |m 1329118723:Mayer, Tobias |d 50000 |e 50000PM1329118723 |k 0/50000/ |p 4 | ||
| 998 | |g 1241910367 |a Kraft, Patricia |m 1241910367:Kraft, Patricia |d 910000 |d 910200 |e 910000PK1241910367 |e 910200PK1241910367 |k 0/910000/ |k 1/910000/910200/ |p 3 | ||
| 998 | |g 1326611658 |a Lian, Shuo |m 1326611658:Lian, Shuo |p 2 | ||
| 998 | |g 1389395367 |a Ming, Ma |m 1389395367:Ming, Ma |d 50000 |e 50000PM1389395367 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1960478435 |e 491221728X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Ming Ma, Shuo Lian, Patricia Kraft, Tobias Mayer, Alex Ali Sayour, Matthias Karck, Gábor Szabó, Sevil Korkmaz-Icöz"]},"id":{"doi":["10.1016/j.bcp.2025.117601"],"eki":["1960478435"]},"physDesc":[{"noteIll":"Illustrationen","extent":"12 S."}],"recId":"1960478435","person":[{"display":"Ma, Ming","given":"Ming","role":"aut","family":"Ma"},{"family":"Lian","given":"Shuo","role":"aut","display":"Lian, Shuo"},{"role":"aut","given":"Patricia","family":"Kraft","display":"Kraft, Patricia"},{"given":"Tobias","role":"aut","family":"Mayer","display":"Mayer, Tobias"},{"family":"Sayour","role":"aut","given":"Alex Ali","display":"Sayour, Alex Ali"},{"display":"Karck, Matthias","family":"Karck","role":"aut","given":"Matthias"},{"display":"Szabó, Gábor","role":"aut","given":"Gábor","family":"Szabó"},{"display":"Korkmaz-İçöz, Sevil","given":"Sevil","role":"aut","family":"Korkmaz-İçöz"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"30631777X","disp":"The sodium-glucose cotransporter-2 inhibitor canagliflozin alleviates endothelial dysfunction in a rat bypass modelBiochemical pharmacology","pubHistory":["1.1958 -"],"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1958","dateIssuedDisp":"1958-","publisher":"Elsevier Science"}],"note":["Gesehen am 21.02.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"title":[{"title":"Biochemical pharmacology","title_sort":"Biochemical pharmacology"}],"part":{"pages":"1-12","year":"2026","volume":"244","text":"244(2026) vom: Feb., Artikel-ID 117601, Seite 1-12","extent":"12"},"id":{"eki":["30631777X"],"issn":["1873-2968"],"zdb":["1496199-4"]}}],"origin":[{"dateIssuedDisp":"February 2026","dateIssuedKey":"2026"}],"note":["Online verfügbar: 4. Dezember 2025, Artikelversion: 8. Dezember 2025","Gesehen am 10.02.2026"],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"sodium-glucose cotransporter-2 inhibitor canagliflozin alleviates endothelial dysfunction in a rat bypass model","title":"The sodium-glucose cotransporter-2 inhibitor canagliflozin alleviates endothelial dysfunction in a rat bypass model"}]} | ||
| SRT | |a MAMINGLIANSODIUMGLUC2026 | ||